Your account is not claimed yet. You can sign up with ORCID to claim your account.

Peter Ferenci (P Ferenci)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 21

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Journal of viral hepatitis

This page only lists publications with an associated author ORCID identifier.

Publications

Mathias Jachs, Thomas Reiberger, Peter Ferenci
Letter: chronic HDV infection-is ignorance bliss? Authors' reply. Alimentary pharmacology & therapeutics 57 (3) (2023)
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Letter: chronic HDV infection-is ignorance bliss? Authors' reply. Alimentary pharmacology & therapeutics 57 (3) (2023)
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply. Alimentary pharmacology & therapeutics 56 (5) (2022)
Marlene Panzer, André Viveiros, Benedikt Schaefer, Nadja Baumgartner, Klaus Seppi, Atbin Djamshidian, Theodor Todorov, William J H Griffiths, Eckart Schott, Markus Schuelke, Dennis Eurich, Albert Friedrich Stättermayer, Adrian Bomford, Pierre Foskett, Julia Vodopiutz, Katharina Staufer, Elke Pertler, Bernhard Morell, Herbert Tilg, Thomas Müller, Stefan Kiechl, Raul Jimenez Heredia, Karl Heinz Weiss, Si Houn Hahn, Andreas Janecke, Peter Ferenci, Heinz Zoller
Synonymous mutation in adenosine triphosphatase copper-transporting beta causes enhanced exon skipping in Wilson disease. Hepatology communications 6 (7) (2022)
Stephan Listabarth, Daniel König, Gabriela Berlakovich, Petra Munda, Peter Ferenci, Dagmar Kollmann, Georg P Gyoeri, Thomas Waldhoer, Magdalena Groemer, Arjan van Enckevort, Benjamin Vyssoki
Sex Disparities in Outcome of Patients with Alcohol-Related Liver Cirrhosis within the Eurotransplant Network-A Competing Risk Analysis. Journal of clinical medicine 11 (13) (2022)
Peter Ferenci, Thomas Reiberger, Vanessa Stadlbauer, Heinz Zoller
Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins? Liver international : official journal of the International Association for the Study of the Liver (2022)
Peter Ferenci, Thomas Reiberger, Mathias Jachs
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update. Cells 11 (22) (2022)
Mathias Jachs, Caroline Schwarz, Marlene Panzer, Teresa Binter, Stephan W Aberle, Lukas Hartl, Kristina Dax, Elmar Aigner, Albert F Stättermayer, Petra Munda, Ivo Graziadei, Heidemarie Holzmann, Michael Trauner, Heinz Zoller, Michael Gschwantler, Mattias Mandorfer, Thomas Reiberger, Peter Ferenci
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study. Alimentary pharmacology & therapeutics 56 (1) (2022)
David Chromy, David Josef Maria Bauer, Benedikt Simbrunner, Matthias Jachs, Lukas Hartl, Philipp Schwabl, Caroline Schwarz, Armin Rieger, Katharina Grabmeier-Pfistershammer, Michael Trauner, Peter Ferenci, Mattias Mandorfer, Michael Gschwantler, Thomas Reiberger
The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals. Journal of viral hepatitis 29 (5) (2022)
Yasser Mahrous Fouad, Jeffrey Victor Lazarus, Francesco Negro, Markus Peck-Radosavljevic, Shiv Kumar Sarin, Peter Ferenci, Gamal Esmat, Hasmik Ghazinian, Atsushi Nakajima, Marcelo Silva, Samuel Lee, Massimo Colombo
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective. Alimentary pharmacology & therapeutics 53 (10) (2021)
Georg Semmler, Teresa Binter, Karin Kozbial, Philipp Schwabl, David Chromy, David Josef Maria Bauer, Benedikt Simbrunner, Theresa Müllner-Bucsics, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, Petra Steindl-Munda, Michael Trauner, Peter Ferenci, Thomas Reiberger, Mattias Mandorfer
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR. Journal of personalized medicine 11 (4) (2021)
Peter Ott, Aftab Ala, Frederick K Askari, Anna Czlonkowska, Ralf-Dieter Hilgers, Aurélia Poujois, Eve A Roberts, Thomas Damgaard Sandahl, Karl Heinz Weiss, Peter Ferenci, Michael L Schilsky
Designing Clinical Trials in Wilson's Disease. Hepatology (Baltimore, Md.) 74 (6) (2021)
Georg Semmler, Teresa Binter, Karin Kozbial, Philipp Schwabl, Stefanie Hametner-Schreil, Alberto Zanetto, Sabrina Gavasso, David Chromy, David Josef Maria Bauer, Benedikt Simbrunner, Bernhard Scheiner, Theresa A Bucsics, Albert F Stättermayer, Matthias Pinter, Petra Steindl-Munda, Rainer Schöfl, Francesco Paolo Russo, Paolo Simioni, Michael Trauner, Peter Ferenci, Thomas Reiberger, Mattias Mandorfer
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease. Hepatology (Baltimore, Md.) 73 (4) (2021)
Rafael Paternostro, Jan Pfeiffenberger, Peter Ferenci, Albert Friedrich Stättermayer, Rudolf E Stauber, Fritz Wrba, Thomas Longerich, Karoline Lackner, Michael Trauner, Arnulf Ferlitsch, Thomas Reiberger, Karl Heinz Weiss
Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease. Liver international : official journal of the International Association for the Study of the Liver 40 (4) (2020)
Peter Ferenci, Wolfgang Stremmel, Anna Członkowska, Ferenc Szalay, André Viveiros, Albert Friedrich Stättermayer, Radan Bruha, Roderick Houwen, Tudor Lucian Pop, Rudolf Stauber, Michael Gschwantler, Jan Pfeiffenberger, Cihan Yurdaydin, Elmar Aigner, Petra Steindl-Munda, Hans-Peter Dienes, Heinz Zoller, Karl Heinz Weiss
Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease. Hepatology (Baltimore, Md.) 69 (4) (2019)
Peter Ferenci
Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations? Alimentary pharmacology & therapeutics 47 (6) (2019)
Mattias Mandorfer, Markus Peck-Radosavljevic, Peter Ferenci, Thomas Reiberger
Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient. Liver international : official journal of the International Association for the Study of the Liver 40 (4) (2019)
Peter Ferenci, Stefan Bourgeois, Peter Buggisch, Suzanne Norris, Manuela Curescu, Dominique Larrey, Fiona Marra, Henning Kleine, Patrick Dorr, Mariem Charafeddine, Eric Crown, Mark Bondin, David Back, Robert Flisiak
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries. Journal of viral hepatitis 26 (6) (2019)
Mattias Mandorfer, Karin Kozbial, Philipp Schwabl, David Chromy, Georg Semmler, Albert F Stättermayer, Matthias Pinter, Virginia Hernández-Gea, Monika Fritzer-Szekeres, Petra Steindl-Munda, Michael Trauner, Markus Peck-Radosavljevic, Joan Carles García-Pagán, Peter Ferenci, Thomas Reiberger
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy. Hepatology (Baltimore, Md.) 71 (3) (2019)
Bernhard Scheiner, Albert Friedrich Stättermayer, Philipp Schwabl, Theresa A Bucsics, Rafael Paternostro, David Bauer, Benedikt Simbrunner, Ralf Schmidt, Rodrig Marculescu, Arnulf Ferlitsch, Markus Peck-Radosavljevic, Matthias Pinter, Michael Trauner, Thomas Reiberger, Peter Ferenci, Mattias Mandorfer
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
Mattias Mandorfer, Bernhard Scheiner, A F Stättermayer, P Schwabl, Rafael Paternostro, D Bauer, Benedikt Schaefer, Heinz Zoller, M Peck-Radosavljevic, M Trauner, Thomas Reiberger, Peter Ferenci, Arnulf Ferlitsch
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. Alimentary pharmacology & therapeutics 48 (4) (2018)

Peter Ferenci.css-eqlu8i{font-size:small;padding-left:4px;} (P Ferenci)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Ferenci (P Ferenci)